C. Aschele

4.9k total citations · 2 hit papers
74 papers, 3.5k citations indexed

About

C. Aschele is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Aschele has authored 74 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 32 papers in Surgery and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Aschele's work include Colorectal Cancer Treatments and Studies (53 papers), Colorectal and Anal Carcinomas (30 papers) and Colorectal Cancer Surgical Treatments (25 papers). C. Aschele is often cited by papers focused on Colorectal Cancer Treatments and Studies (53 papers), Colorectal and Anal Carcinomas (30 papers) and Colorectal Cancer Surgical Treatments (25 papers). C. Aschele collaborates with scholars based in Italy, United Kingdom and United States. C. Aschele's co-authors include Alberto Sobrero, Joseph R. Bertino, Rob Glynne‐Jones, Dirk Arnold, Vicky Goh, D. Peiffert, Andrés Cervantes, Per J. Nilsson, Sara Lonardi and Domizia Debernardis and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

C. Aschele

74 papers receiving 3.4k citations

Hit Papers

Primary Tumor Response to Preoperative Chemoradiation Wit... 2011 2026 2016 2021 2011 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
    2011 535 citations C. Aschele, L. Cionini et al. Journal of Clinical Oncology profile →
  2. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
    2014 386 citations C. Aschele et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Aschele Italy 27 2.6k 1.7k 1.2k 471 432 74 3.5k
Takashi Ura Japan 28 1.8k 0.7× 1.3k 0.8× 1.7k 1.4× 338 0.7× 539 1.2× 136 3.5k
J. S. Macdonald United States 24 2.8k 1.1× 1.3k 0.8× 924 0.8× 662 1.4× 440 1.0× 68 3.8k
Ángel J. Lacave Spain 19 1.9k 0.7× 2.8k 1.7× 1.3k 1.1× 416 0.9× 669 1.5× 49 5.7k
Michael Findlay New Zealand 29 1.6k 0.6× 814 0.5× 988 0.8× 456 1.0× 601 1.4× 111 3.3k
Jean François Seitz France 18 2.8k 1.1× 842 0.5× 1.0k 0.9× 974 2.1× 418 1.0× 37 3.7k
Akihito Tsuji Japan 24 1.9k 0.7× 671 0.4× 1.6k 1.3× 358 0.8× 370 0.9× 184 2.8k
D. Depisch Austria 28 2.0k 0.8× 939 0.6× 895 0.8× 240 0.5× 395 0.9× 82 2.7k
Yong Sang Hong South Korea 33 3.5k 1.3× 1.9k 1.2× 1.3k 1.1× 618 1.3× 834 1.9× 208 4.8k
J. Wils Netherlands 30 2.9k 1.1× 1.2k 0.7× 1.8k 1.6× 513 1.1× 588 1.4× 79 4.2k
Carlo Barone Italy 31 2.3k 0.9× 671 0.4× 1.4k 1.2× 461 1.0× 769 1.8× 130 3.6k

Countries citing papers authored by C. Aschele

Since Specialization
Citations

This map shows the geographic impact of C. Aschele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Aschele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Aschele more than expected).

Fields of papers citing papers by C. Aschele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Aschele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Aschele. The network helps show where C. Aschele may publish in the future.

Co-authorship network of co-authors of C. Aschele

This figure shows the co-authorship network connecting the top 25 collaborators of C. Aschele. A scholar is included among the top collaborators of C. Aschele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Aschele. C. Aschele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ciarmiello, Andrea, Elisabetta Giovannini, Amalia Milano, et al.. (2024). Does FDG PET-Based Radiomics Have an Added Value for Prediction of Overall Survival in Non-Small Cell Lung Cancer?. Journal of Clinical Medicine. 13(9). 2613–2613. 4 indexed citations
2.
Ciarmiello, Andrea, Luigia Florimonte, Claudia Bareggi, et al.. (2021). 1137P Machine learning radiomics for prediction of survival in non-small cell lung cancer patients studied with PET/CT and FDG. Annals of Oncology. 32. S926–S926. 1 indexed citations
3.
Conti, E., et al.. (2021). Clear-cell renal cell carcinoma single thyroid metastasis: A single-center retrospective analysis and review of the literature. Archivio Italiano di Urologia e Andrologia. 93(1). 68–70. 4 indexed citations
4.
Indini, Alice, Graziella Pinotti, Fabrizio Artioli, et al.. (2021). Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave. European Journal of Cancer. 148. 112–116. 6 indexed citations
5.
Aschele, C., Maria Emanuela Negru, Alessandro Pastorino, et al.. (2020). Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy. JAMA Oncology. 7(2). 304–304. 16 indexed citations
6.
Salvatore, Lisa, Giuseppe Aprile, Ermenegildo Arnoldi, et al.. (2017). Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM). ESMO Open. 2(1). e000147–e000147. 33 indexed citations
7.
Lonardi, Sara, L. Cionini, Francesca Di Fabio, et al.. (2016). Analysis of early distant metastases of STAR-01: A randomized phase III trial comparing preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer.. Journal of Clinical Oncology. 34(15_suppl). e15149–e15149. 1 indexed citations
8.
Francone, Elisa, et al.. (2016). Precoagulation-assisted parenchyma-sparing laparoscopic liver surgery: rationale and surgical technique. Surgical Endoscopy. 31(3). 1354–1360. 6 indexed citations
9.
Aschele, C., L. Cionini, Sara Lonardi, et al.. (2011). Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial. Journal of Clinical Oncology. 29(20). 2773–2780. 535 indexed citations breakdown →
10.
Fabio, Francesco Di, Carmine Pinto, Evaristo Maiello, et al.. (2009). 6045 Safety analysis of starpan (star-02) study with panitumumab, 5-fluorouracil, oxaliplatin and concurrent radiotherapy in locally advanced rectal cancer. European Journal of Cancer Supplements. 7(2). 335–335. 1 indexed citations
11.
Pucciarelli, Salvatore, Emanuele Damiano Luca Urso, Gian Luca De Salvo, et al.. (2006). 5-Fluorouracil and Weekly Oxaliplatin Combined with Radiotherapy for Locally Advanced Rectal Cancer: Surgical Complications and Long-term Results. Archives of Medical Research. 37(7). 860–865. 8 indexed citations
12.
Aschele, C., Gian Andrea Binda, Franco Decian, et al.. (2004). A phase I study of uracil/tegafur (UFT) and oral leucovorin (LV) + weekly oxaliplatin (OXA) and preoperative radiotherapy (RT) in locally advanced rectal cancer (LARC). Journal of Clinical Oncology. 22(14_suppl). 3637–3637. 6 indexed citations
13.
Pasetto, Lara Maria, Sara Lonardi, C. Caroti, et al.. (2004). Phase I study of weekly oxaliplatin (OXA) + 5-fluorouracil continuous infusion (FU CI) in patients (pts) with advanced colorectal cancer (CRC). Journal of Clinical Oncology. 22(14_suppl). 3770–3770. 4 indexed citations
14.
Jodrell, Duncan I., T.R. Jeffry Evans, William P. Steward, et al.. (2004). Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma. European Journal of Cancer. 40(12). 1872–1877. 104 indexed citations
15.
Gérard, Jean‐Pierre, et al.. (2003). Radiochemotherapy in rectal cancer: the role of oxaliplatin. Colorectal Disease. 5(s3). 29–35. 3 indexed citations
16.
Aschele, C., Sara Lonardi, & S. Monfardini. (2002). Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer. Cancer Treatment Reviews. 28(1). 27–47. 77 indexed citations
17.
Sobrero, Alberto, Alfredo Guglielmi, Massimo Círillo, et al.. (2001). 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer. British Journal of Cancer. 84(8). 1023–1028. 12 indexed citations
18.
19.
Aschele, C., Domizia Debernardis, G Tunesi, Frank Maley, & Alberto Sobrero. (2000). Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil.. PubMed. 6(12). 4797–802. 81 indexed citations
20.
Guglielmi, Alfredo, C. Aschele, A. Mori, et al.. (1995). In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.. PubMed. 1(11). 1337–44. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takashi Ura Breakdown of academic impact, for papers by J. S. Macdonald Breakdown of academic impact, for papers by Ángel J. Lacave Breakdown of academic impact, for papers by Michael Findlay Breakdown of academic impact, for papers by Jean François Seitz Breakdown of academic impact, for papers by Akihito Tsuji Breakdown of academic impact, for papers by D. Depisch Breakdown of academic impact, for papers by Yong Sang Hong Breakdown of academic impact, for papers by J. Wils Breakdown of academic impact, for papers by Carlo Barone
Rankless by CCL
2026